Miniatura

Fitxers

635286.pdf (204.59 KB)

Tipus de document

Article

Versió

Versió publicada

Data de publicació

2010-01-19

Llicència de publicació

cc-by (c) Gonzalo, Victoria et al., 2010
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/124842

Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer

Títol de la revista

Autors

Director/Tutor

ISSN de la revista

Títol del volum

Recurs relacionat

https://doi.org/10.1371/journal.pone.0008777

Resum

Background Colorectal cancer (CRC) multiplicity has been mainly related to polyposis and non-polyposis hereditary syndromes. In sporadic CRC, aberrant gene promoter methylation has been shown to play a key role in carcinogenesis, although little is known about its involvement in multiplicity. To assess the effect of methylation in tumor multiplicity in sporadic CRC, hypermethylation of key tumor suppressor genes was evaluated in patients with both multiple and solitary tumors, as a proof-of-concept of an underlying epigenetic defect. Methodology/Principal Findings We examined a total of 47 synchronous/metachronous primary CRC from 41 patients, and 41 gender, age (5-year intervals) and tumor location-paired patients with solitary tumors. Exclusion criteria were polyposis syndromes, Lynch syndrome and inflammatory bowel disease. DNA methylation at the promoter region of the MGMT, CDKN2A, SFRP1, TMEFF2, HS3ST2 (3OST2), RASSF1A and GATA4 genes was evaluated by quantitative methylation specific PCR in both tumor and corresponding normal appearing colorectal mucosa samples. Overall, patients with multiple lesions exhibited a higher degree of methylation in tumor samples than those with solitary tumors regarding all evaluated genes. After adjusting for age and gender, binomial logistic regression analysis identified methylation of MGMT2 (OR, 1.48; 95% CI, 1.10 to 1.97; p = 0.008) and RASSF1A (OR, 2.04; 95% CI, 1.01 to 4.13; p = 0.047) as variables independently associated with tumor multiplicity, being the risk related to methylation of any of these two genes 4.57 (95% CI, 1.53 to 13.61; p = 0.006). Moreover, in six patients in whom both tumors were available, we found a correlation in the methylation levels of MGMT2 (r = 0.64, p = 0.17), SFRP1 (r = 0.83, 0.06), HPP1 (r = 0.64, p = 0.17), 3OST2 (r = 0.83, p = 0.06) and GATA4 (r = 0.6, p = 0.24). Methylation in normal appearing colorectal mucosa from patients with multiple and solitary CRC showed no relevant difference in any evaluated gene. Conclusions These results provide a proof-of-concept that gene promoter methylation is associated with tumor multiplicity. This underlying epigenetic defect may have noteworthy implications in the prevention of patients with sporadic CRC.

Matèries

Càncer colorectal, Genètica humana, Metilació, ADN

Matèries (anglès)

Colorectal cancer, Human genetics, Methylation, DNA

Citació

Col·leccions

Articles publicats en revistes (Medicina)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)

Citació

GONZALO, Victoria, LOZANO SALVATELLA, Juan josé, MUÑOZ, Jenifer, BALAGUER PRUNÉS, Francesc, PELLISÉ URQUIZA, Maria, RODRÍGUEZ DE MIGUEL, Cristina, ANDREU, Montserrat, JOVER, Rodrigo, LLOR, Xavier, GIRALDEZ, Maria dolores, OCAÑA, Teresa, SERRADESANFERM, Anna, ALONSO-ESPINACO, Virginia, JIMENO, Mireya, CUATRECASAS FREIXAS, Miriam, SENDINO, Oriol, CASTELLVÍ BEL, Sergi, CASTELLS GARANGOU, Antoni. Aberrant gene promoter methylation associated with sporadic multiple colorectal cancer. _PLoS One_. 2010. Vol. 5, núm. 1, pàgs. e8777. [consulta: 8 de febrer de 2026]. ISSN: 1932-6203. [Disponible a: https://hdl.handle.net/2445/124842]

Exportar metadades

JSON - METS

Compartir registre